Angiotensin II Regulates Excitability and Contractile Functions of Myocardium and Smooth Muscles through Autonomic Nervous Transmission

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Fumiko YamakiYoshio Tanaka

Abstract

Angiotensin II (Ang II) is an intrinsic peptide having strong vasopressor effects, and thus, it plays an important role in the physiological regulation of blood pressure. The vasopressor effects of Ang II include direct contraction of myocardium and vascular smooth muscles (SMs) along with aldosterone-mediated sodium retention. In addition, indirect vascular contractions induced by noradrenaline (NA), the release of which is mediated through Ang II receptor type 1 (AT1) existing at the sympathetic nerve terminals (SNTs), also contribute to the vasopressor effects of Ang II. Stimulation of NA release from SNTs by Ang II also occurs in the myocardium leading to an increase in heart rate and cardiac contraction. Furthermore, Ang II enhances the contractions of non-vascular SMs, such as vas deferens, through induction of NA release from the SNTs. We have found that Ang II attenuated vagus nerve stimulation-induced bradycardia in a losartan-sensitive manner. This suggests that Ang II attenuates vagus nerve stimulation-induced bradycardia by inhibiting acetylcholine (ACh) release from the parasympathetic nerve terminals (PNTs) through activation of the AT1 receptor. Ang II was also reported to attenuate the release of ACh from the PN...Continue Reading

References

Feb 1, 1979·The American Journal of Physiology·W B Campbell, E K Jackson
Jul 1, 1978·European Journal of Pharmacology·M KobayashiS Chiba
Feb 1, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·T EndoH D Taube
Feb 9, 1988·European Journal of Pharmacology·G J Trachte
Dec 1, 1988·Clinical and Experimental Pharmacology & Physiology·M P RechtmanA L Boura
Sep 1, 1985·Journal of the Autonomic Nervous System·S F Hobbs, E K Potter
Feb 1, 1971·British Journal of Pharmacology·J Hughes, R H Roth
Feb 1, 1994·The Journal of Clinical Investigation·B ClemsonR Zelis
Sep 1, 1993·British Journal of Pharmacology·M Rechtman, H Majewski
Jul 1, 1996·British Journal of Pharmacology·C S SumW T Cheung
Sep 1, 1996·Hypertension Research : Official Journal of the Japanese Society of Hypertension·M NagaseT Fujita
Aug 29, 2000·Journal of Autonomic Pharmacology·D MouraS Guimarães
Oct 5, 2002·Hypertension·Thomas W LamerisAnton H van den Meiracker
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Robson A S SantosThomas Walther
Jan 13, 2004·Journal of Cardiovascular Pharmacology·Malek El MuayedLars Christian Rump
May 15, 2004·Progress in Neurobiology·John W Wright, Joseph W Harding
Jul 4, 2006·Physiological Reviews·Martin PaulReinhold Kreutz
Jul 24, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Toru KawadaMasaru Sugimachi
Oct 7, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Mirnela BykuThomas C Westfall
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·Michael Bader

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.